13
© 2014 Jefferies LLC. Member SIPC. AGENDA JUNE 2-5, 2014 Grand Hyatt New York City Jefferies 2014 Global Healthcare Conference You are invited to attend the Jefferies 2014 Global Healthcare Conference taking place June 2-5 at the Grand Hyatt in New York City. Following the success of last year’s event, with over 300 participating companies and 2,500 attendees, the conference will again feature an extensive range of public & private healthcare companies across the biopharmaceuticals, life sciences, healthcare services, healthcare IT and medical technology sectors. This global gathering of leading executives, institutional investors, private equity investors and VCs will address near- and long-term investment opportunities and discuss the mechanisms driving healthcare in the U.S. and internationally. The four day conference will be comprised of company presentations, Q&A breakout sessions, keynotes and thematic panels. Company management teams and investors will also have the opportunity to participate in 1x1 and small group meetings. To register, please contact your Jefferies representative. For questions, please email: [email protected]

JUNE 2-5, 2014 - · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

Embed Size (px)

Citation preview

Page 1: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

© 2014 Jefferies LLC. Member SIPC.

AGENDA JUNE 2-5, 2014 Grand Hyatt New York City

Jefferies 2014 Global Healthcare Conference You are invited to attend the Jefferies 2014 Global Healthcare Conference taking place June 2-5 at the Grand Hyatt in New York City. Following the success of last year’s event, with over 300 participating companies and 2,500 attendees, the conference will again feature an extensive range of public & private healthcare companies across the biopharmaceuticals, life sciences, healthcare services, healthcare IT and medical technology sectors. This global gathering of leading executives, institutional investors, private equity investors and VCs will address near- and long-term investment opportunities and discuss the mechanisms driving healthcare in the U.S. and internationally. The four day conference will be comprised of company presentations, Q&A breakout sessions, keynotes and thematic panels. Company management teams and investors will also have the opportunity to participate in 1x1 and small group meetings. To register, please contact your Jefferies representative. For questions, please email: [email protected]

Page 2: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

AGENDA MONDAY, JUNE 2, 2014 Jefferies 2014 Global Healthcare Conference

** Company not hosting a breakout session Presenting companies and speakers are subject to change.

BALLROOM I, BREAKOUT ROOM: URIS

BALLROOM II BREAKOUT ROOM: JUILLIARD

BALLROOM III BREAKOUT ROOM: BROADWAY

BALLROOM IV BREAKOUT ROOM: CARNEGIE HALL

BALLROOM V BREAKOUT ROOM: ALVIN

MOROSCO, CONFERENCE LEVEL BREAKOUT ROOM: PLYMOUTH

7:30 AM Breakfast/Registration (Ballroom Level)

8:00 AM Inovio Pharmaceuticals, Inc. (NYSE:INO) Biotechnology Dr. Joseph Kim, CEO

Revance Therapeutics, Inc. (NasdaqGM:RVNC) Pharmaceuticals Dan Browne, President & CEO

Enzo Biochem, Inc. (NYSE:ENZ) Life Sciences Barry Weiner, President

Conatus Pharmaceuticals Inc. (NasdaqGM:CNAT)** Biotechnology Steven Mento, President & CEO

Biota Pharmaceuticals, Inc. (NasdaqGS:BOTA) Biotechnology Joseph Patti, PhD, EVP, Corp Development & Strategy

8:30 AM Transition Therapeutics Inc. (TSX:TTH) Biotechnology Tony Cruz, CEO

Enanta Pharmaceuticals, Inc. (NasdaqGS:ENTA) Biotechnology Jay R. Luly, President & CEO

MEDNAX, Inc. (NYSE:MD) Healthcare Services Vivian Lopez Blanco, CFO

Kindred Biosciences, Inc. (NasdaqCM:KIN)** Biotechnology Richard Chin, CEO

BioClinica, Inc. (Private) Life Sciences Mark Weinstein, President & CEO; Ted Kaminer, EVP & CFO

9:00 AM Aerie Pharmaceuticals, Inc. (NasdaqGM:AERI) Biotechnology Rich Rubino, CFO

The Medicines Company (NasdaqGS:MDCO) Pharmaceuticals Clive Meanwell, MD, PhD, CEO

Globus Medical, Inc. (NYSE:GMED) Medical Products & Devices Richard Baron, SVP & CFO

Amedisys, Inc. (NasdaqGS:AMED) Healthcare Services Ronald LaBorde, Interim CEO & President; Dale Redman, Interim CFO

Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

Heptares Therapeutics Ltd. (Private) Biotechnology Malcolm Weir, CEO

9:30 AM Oramed Pharmaceuticals Inc. (NasdaqCM:ORMP) Pharmaceuticals Nadav Kidron, CEO

Cambrex Corp (NYSE:CBM) Life Sciences Steven Klosk, President & CEO

Shire plc (LSE:SHP) Pharmaceuticals Flemming Ornskov, CEO

Cantel Medical Corp (NYSE:CMN) Medical Products & Devices Andrew Krakauer, President & CEO

uniQure N.V. (NasdaqGS:QURE) Biotechnology Jörn Aldag, CEO

Juno Therapeutics Inc. (Private)** Biotechnology Hans Bishop, CEO

10:00 AM Dicerna Pharmaceuticals, Inc. (NasdaqGS:DRNA) Biotechnology Doug Fambrough, CEO

Insulet Corporation (NasdaqGS:PODD) Medical Products & Devices Brian Roberts, CFO

Perrigo Co. (NYSE:PRGO) Pharmaceuticals Joe Papa, President & CEO

ACADIA Pharmaceuticals Inc. (NasdaqGS:ACAD) Biotechnology Uli Hacksell, CEO

Organovo Holdings, Inc. (NYSEMKT:ONVO) Life Sciences Keith Murphy, CEO

Nora Therapeutics, Inc. (Private) Pharmaceuticals Jeffrey Tong, CEO

10:30 AM Flexion Therapeutics (NasdaqGM: FLXN) Biotechnology Michael Clayman, CEO

DYAX Corp (NasdaqGM:DYAX) Biotechnology Gustav Christensen, President & CEO

Stryker Corp. (NYSE:SYK) Medical Products & Devices Katherine Owen, VP, Strategy & IR

Bio-Rad Laboratories, Inc. (NYSE:BIO) Life Sciences Norman Schwartz, President & CEO

RadNet, Inc. (NasdaqGM:RDNT) Healthcare Services Mark Stolper, EVP & CFO

Avion Pharmaceuticals, LLC (Private) Pharmaceuticals Michael Sullivan, President

11:00 AM Galectin Therapeutics, Inc. (NasdaqCM:GALT) Biotechnology Harold Shlevin, COO

Alkermes plc (NasdaqGS:ALKS) Biotechnology Jim Frates, CFO

Cepheid (NasdaqGS:CPHD) Life Sciences John Bishop, Chairman & CEO

Pacira Pharmaceuticals Inc. (NasdaqGS:PCRX) Pharmaceuticals Dave Stack, President, CEO & Chairman

Trevena, Inc. (NasdaqGS:TRVN) Biotechnology Maxine Gowen, President & CEO

CytomX Therapeutics, Inc. (Private) Biotechnology Sean McCarthy, CEO

11:30 AM Unilife Corporation (NasdaqGM:UNIS) Medical Products & Devices Alan Shortall, Chairman & CEO; Stephen Allan, VP, Marketing & Communication

Ablynx NV (ENXTBR:ABLX) Biotechnology Edwin Moses, CEO

Roche Holding Ltd (SWX:ROG) Pharmaceuticals Alan Hippe, CFO Roche Group

NPS Pharmaceuticals Inc. (NasdaqGS:NPSP) Biotechnology Francois Nader, MD, President & CEO

Neostem, Inc. (NasdaqCM:NBS) Biotechnology Robin Smith, Chairman & CEO

Elements Behavioral Health, Inc. (Private)** Healthcare Services David Sack, President & CEO

Page 3: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

AGENDA MONDAY, JUNE 2, 2014 Jefferies 2014 Global Healthcare Conference

** Company not hosting a breakout session Presenting companies and speakers are subject to change.

BALLROOM I BREAKOUT ROOM: URIS

BALLROOM II BREAKOUT ROOM: JUILLIARD

BALLROOM III BREAKOUT ROOM: BROADWAY

BALLROOM IV BREAKOUT ROOM: CARNEGIE HALL

BALLROOM V BREAKOUT ROOM: ALVIN

MOROSCO, CONFERENCE LEVEL BREAKOUT ROOM: PLYMOUTH

12:00 PM Break for Lunch (Ballroom Level)

12:15 PM KEYNOTE: Global Macro Outlook (Ballrooms 2-4) David Zervos, Chief Market Strategist, Jefferies LLC

1:30 PM BIND Therapeutics, Inc. (NasdaqGS:BIND) Biotechnology Scott Minick, President & CEO

West Pharmaceutical Services, Inc. (NYSE:WST) Medical Products & Devices Donald Morel, Chairman & Chief Executive; William Federici, CFO

Sigma-Aldrich Corporation (NasdaqGS:SIAL) Life Sciences Gilles Cottier, EVP & President, SAFC Commercial BU; Quin Lai, VP, IR & Strategy

IPC The Hospitalist Company, Inc. (NasdaqGS:IPCM) Healthcare Services Adam Singer, CEO; Jeffrey Taylor, President

Immunomedics, Inc. (NasdaqGM:IMMU) Biotechnology Cynthia Sullivan, President & CEO

Edison Pharmaceuticals, Inc. (Private)** Pharmaceuticals Guy Miller, Chairman & CEO

2:00 PM BioSpecifics Technologies Corp. (NasdaqGM:BSTC) Biotechnology Thomas Wegman, President

WuXi PharmaTech (Cayman) Inc. (NYSE:WX) Healthcare Services Edward Hu, COO & CFO; Ronald Aldridge, Director of IR

Henry Schein, Inc. (NasdaqGS:HSIC) Healthcare Services Stanley Bergman, Chairman of the Board & CEO

Abiomed Inc (NasdaqGS:ABMD) Medical Products & Devices Michael Minogue, Chairman, President & CEO

Almost Family, Inc. (NasdaqGS:AFAM) Healthcare Services William Yarmuth, Chairman & CEO; Steve Guenthner, President

Zebra Biologics, Inc. (Private) Biotechnology Ronald Lindsay, Chairman & CEO

2:30 PM Evotec AG (XTRA:EVT) Life Sciences Werner Lanthaler, CEO

Aegerion Pharmaceuticals, Inc. (NasdaqGS:AEGR) Biotechnology Marc Beer, CEO

MannKind Corporation (NasdaqGM:MNKD) Biotechnology Matthew Pfeffer, Corporate VP & CFO

Acorda Therapeutics, Inc. (NasdaqGS:ACOR) Biotechnology Michael Rogers, CFO

Physicians Realty Trust (NYSE:DOC) REITs John Thomas, President & CEO; John Sweet, EVP & CIO; Mark Theine, SVP of Asset & Investment Mgmt

MHM Services, Inc. (Private) ** Healthcare Services Michael Pinkert, Chairman & CEO

3:00 PM Heron Therapeutics, Inc. (NasdaqCM:HRTX) Biotechnology Barry Quart, CEO

Abaxis Inc (NasdaqGS:ABAX) Life Sciences Clint Severson, Chairman, President & CEO

Community Health Systems, Inc. (NYSE:CYH)** Healthcare Services Larry Cash, President, Financial Services & CFO

Hanger, Inc. (NYSE:HGR) Healthcare Services Vinit Asar, CEO

Aquinox Pharmaceuticals Inc. (NasdaqGM:AQXP) Pharmaceuticals David Main, President & CEO

Direct Flow Medical, Inc. (Private) Medical Products & Devices Bernard Lyons, President & CEO

3:30 PM Anacor Pharmaceuticals, Inc. (NasdaqGM:ANAC) Pharmaceuticals Paul Berns, CEO

Horizon Pharma, Inc. (NasdaqGS:HZNP) Pharmaceuticals Tim Walbert, Chairman, President & CEO

Senior Housing Properties Trust (NYSE:SNH) REITs David Hegarty, President & COO; Rick Doyle, CFO

Albany Molecular Research, Inc. (NasdaqGS:AMRI) Healthcare Services William Marth, President & CEO; Michael Nolan, VP, CFO & Treasurer

Merge Healthcare Inc. (NasdaqGS:MRGE) Healthcare Services Justin Dearborn, CEO

NephroGenex, Inc (NasdaqCM:NRX) Biotechnology Pierre Legault, CEO

4:00 PM Protalix Biotherapeutics (AMEX:PLX)** Biotechnology David Aviezer, CEO

Genomic Health (NasdaqGS:GHDX) Life Sciences Brad Cole, COO; Emily Faucette, VP, Corp Comm & IR

H. Lundbeck A/S (CPSE:LUN) Pharmaceuticals Palle Holm Olesen, Head of IR

Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE) Biotechnology Shalini Sharp, SVP & CFO

Kindred Healthcare Inc. (NYSE:KND) Healthcare Services Paul Diaz, CEO; Benjamin Breier, President & COO; Stephen Farber, EVP & CFO

Pharmascience Inc. (Private) Pharmaceuticals David Goodman, CEO

4:30 PM TrovaGene, Inc. (NasdaqCM:TROV) Biotechnology Stephen Zaniboni, CFO

STAAR Surgical Co. (NasdaqGM:STAA) Medical Products & Devices Barry Caldwell, President & CEO; Steve Brown, CFO

Nanosphere, Inc. (NasdaqGM:NSPH) Life Sciences Michael McGarrity, President & CEO

Sophiris Bio, Inc. (TSX:SHS) Biotechnology Randall Woods, President & CEO

Health Insurance Innovations, Inc. (NasdaqGM:HIIQ) Healthcare Services Michael Kosloske, President & CEO; Jim Dietz, CFO

Page 4: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

AGENDA TUESDAY, JUNE 3, 2014 Jefferies 2014 Global Healthcare Conference

** Company not hosting a breakout session Presenting companies and speakers are subject to change.

BALLROOM I BREAKOUT ROOM: URIS

BALLROOM II BREAKOUT ROOM: JUILLIARD

BALLROOM III BREAKOUT ROOM: BROADWAY

BALLROOM IV BREAKOUT ROOM: CARNEGIE HALL

BALLROOM V BREAKOUT ROOM: ALVIN

MOROSCO, CONFERENCE LEVEL BREAKOUT ROOM: PLYMOUTH

7:30 AM Breakfast/Registration (Ballroom Level)

8:00 AM Prothena Corporation plc (NasdaqGM:PRTA)** Biotechnology Dale Schenk, President & CEO

Integra LifeSciences Holdings Corporation (NasdaqGS:IART)** Medical Products & Devices Peter Arduini, President & CEO

Medivation, Inc. (NasdaqGS:MDVN) Biotechnology David Hung, MD, President & CEO

OvaScience, Inc. (NasdaqGM:OVAS) Biotechnology Michelle Dipp, CEO

Alcobra Ltd. (NasdaqCM:ADHD) Biotechnology Yaron Daniely, CEO

RXi Pharmaceuticals Corporation (NASDAQ: RXII) Biotechnology Geert Cauwenbergh, President & CEO

8:30 AM Ampio Pharmaceuticals, Inc. (AMEX:AMPE) Biotechnology Vaughan Clift, CMO; Josh Disbrow, COO

Oxford Immunotec Global PLC (NasdaqGM:OXFD) Medical Products & Devices Peter Wrighton-Smith, CEO; Richard Altieri, CFO

Royal Philips (ENXTAM:PHIA) Medical Products & Devices Abhijit Bhattacharya, CFO Philips Healthcare

ICON plc (NasdaqGS:ICLR) Healthcare Services Brendan Brennan, CFO

Pharming Group NV (ENXTAM:PHARM) Biotechnology Sijmen De Vries, CEO

Collegium Pharmaceutical, Inc. (Private) Pharmaceuticals Mike Heffernan, CEO

9:00 AM Lexicon Pharmaceuticals, Inc. (NasdaqGS:LXRX) Biotechnology Arthur Sands, President & CEO

DENTSPLY International Inc. (NasdaqGS:XRAY)** Medical Products & Devices Chris Clark, President & CFO

Teva Pharmaceutical Industries Limited (NasdaqGS:TEVA) Pharmaceuticals Jon Congleton, SVP & Head of Global CNS

VCA Antech Inc. (NasdaqGS:WOOF) Healthcare Services Tomas Fuller, CFO

SciClone Pharmaceuticals, Inc. (NasdaqGS:SCLN) Biotechnology Friedhelm Blobel, CEO

Bellicum Pharmaceuticals, Inc. (Private) Biotechnology Tom Farrell, CEO

9:30 AM MiMedx Group, Inc. (NasdaqCM:MDXG) Medical Products & Devices Bill Taylor, President & COO; Michael Senken, CFO

Akorn, Inc. (NasdaqGS:AKRX) Pharmaceuticals Tim Dick, CFO

Covance Inc. (NYSE:CVD) Life Sciences Joseph Herring, Chairman of the Board & CEO; Paul Surdez, VP, IR

MWI Veterinary Supply (NasdaqGS:MWIV)** Healthcare Services Jim Cleary, CEO; Mary Pat Thompson, SVP, Finance & Admin & CFO

Aratana Therapeutics, Inc. (NasdaqGM:PETX) Biotechnology Steven St. Peter, President & CEO

Aurinia Pharmaceuticals Inc. (TSXV:AUP) Biotechnology Stephen Zaruby, CEO

10:00 AM Pain Therapeutics, Inc. (NasdaqGS:PTIE) Biotechnology Remi Barbier, President & CEO

Align Technology Inc. (NasdaqGS:ALGN) Medical Products & Devices Shirley Stacy, VP, IR & Corporate Communication

Medical Properties Trust (NYSE:MPW)** REITs Edward K. Aldag, Jr., Chairman, President & CEO; R. Steven Hamner, EVP & CFO

Auxilium Pharmaceuticals, Inc. (NasdaqGS:AUXL) Pharmaceuticals Adrian Adams, CEO & President

GlycoMimetics, Inc. (NasdaqGM:GLYC) Biotechnology Rachel King, CEO

PaxVax, Inc. (Private) Biotechnology Ken Kelley, CEO

10:30 AM Ambit Biosciences Corporation (NasdaqGM:AMBI) Biotechnology Mike Martino, CEO

TherapeuticsMD, Inc. (AMEX:TXMD) Pharmaceuticals Robert Finizio, CEO

Cerner Corporation (NasdaqGS:CERN) Healthcare Services Marc Naughton, EVP & CFO

Acadia Healthcare Company (NasdaqGS:ACHC) Healthcare Services Joey Jacobs, Chairman & CEO; Brent Turner, President

Stemline Therapeutics, Inc. (NasdaqCM:STML) Biotechnology Ivan Bergstein, CEO

Intuity Medical, Inc. (Private) Medical Products & Devices Emory Anderson, President & CEO

11:00 AM Cempra, Inc. (NasdaqGM:CEMP) Biotechnology Prabhavathi Fernandes, President & CEO

DepoMed Inc. (NasdaqGS:DEPO) Pharmaceuticals James Schoeneck, President & CEO

Charles River Laboratories International, Inc. (NYSE:CRL) Healthcare Services James Foster, Chairman, President & CEO

Magellan Health Services, Inc. (NasdaqGS:MGLN) Healthcare Services Jonathan Rubin, CFO

Bruker Corporation (NasdaqGS:BRKR) Life Sciences Frank Laukien, CEO

AMN Healthcare Services, Inc. (NYSE:AHS) Healthcare Services Brian Scott, CFO

11:30 AM Genmab AS (CPSE:GEN) Biotechnology Jan van de Winkel, CEO

Arena Pharmaceuticals, Inc. (NasdaqGS:ARNA) Biotechnology Craig Audet, SVP, Operations & Global Regulatory Affairs

Agilent Technologies Inc. (NYSE:A)** Life Sciences Mike McMullen, President, Chemical Analysis Group

Swedish Orphan Biovitrum AB (OM:SOBI) Pharmaceuticals Geoffrey McDonough, President & CEO

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) Healthcare Services William J. Grubbs, President & CEO

Targacept, Inc. (NasdaqGS:TRGT) Biotechnology Stephen Hill, President & CEO

Page 5: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

AGENDA TUESDAY, JUNE 3, 2014 Jefferies 2014 Global Healthcare Conference

** Company not hosting a breakout session Presenting companies and speakers are subject to change.

BALLROOM I BREAKOUT ROOM: URIS

BALLROOM II BREAKOUT ROOM: JUILLIARD

BALLROOM III BREAKOUT ROOM: BROADWAY

BALLROOM IV BREAKOUT ROOM: CARNEGIE HALL

BALLROOM V BREAKOUT ROOM: ALVIN

MOROSCO, CONFERENCE LEVEL BREAKOUT ROOM: PLYMOUTH

12:00 PM Break for Lunch (Ballroom Level)

12:15 PM

PANEL: Reform Remix: What’s Next for Healthcare (Ballrooms 2-4)

Moderators: Brian Tanquilut, Senior Analyst, Healthcare Service, Jefferies LLC & David Windley, Senior Analyst, Managed Care, HCIT & Pharma Services, Jefferies LLC

Featuring: Katie Mahoney, Executive Director, Health Policy, US Chamber of Commerce Michael Ramlet, Founder and Publisher, The Morning Consult Mike Schatzlein, Chief Executive Officer, Saint Thomas Health

1:30 PM Hyperion Therapeutics, Inc. (NasdaqGM:HPTX) Biotechnology Donald J. Santel, President & CEO

EXACT Sciences Corp (NasdaqCM:EXAS) Life Sciences Kevin Conroy, President & CEO

AstraZeneca PLC (LSE:AZN)** Pharmaceuticals Karl Hard, Interim VP, IR

Quintiles Transnational Holdings Inc. (NYSE:Q) Life Sciences Kevin Gordon, CFO

AcelRx Pharmaceuticals, Inc. (NasdaqGM:ACRX) Biotechnology Richard King, President & CEO; Tim Morris, CFO

Concert Pharmaceuticals, Inc. (NasdaqGM:CNCE) Biotechnology Roger Tung, President & CEO

2:00 PM ChromaDex Corporation (OTCPK:CDXC) Life Sciences Frank Jaksch, CEO & Founder

Sequenom Inc. (NasdaqGS:SQNM) Life Sciences Bill Welch, President & COO; Carolyn Beaver, CAO

Seattle Genetics Inc. (NasdaqGS:SGEN) Biotechnology Chris Boerner, EVP, Commercial

XOMA Corporation (NasdaqGM:XOMA) Biotechnology John Varian, CEO; Fred Kurland, CFO; Paul Rubin, CMO

Medivir AB (OM:MVIR B)** Biotechnology Maris Hartmanis, CEO & President

Cellular Dynamics International, Inc. (NasdaqGM:ICEL) Life Sciences Robert Palay, Chairman & CEO

2:30 PM Rigel Pharmaceuticals, Inc. (NasdaqGS:RIGL) Biotechnology James Gower, Chairman & CEO

OpKo Health, Inc (NYSE:OPK) Pharmaceuticals Phillip Frost, Chairman of the Board & CEO; Charles Bishop, CEO, OPK Renal Division; Dave Okrongly, President, OPKO Diagnostics

Catamaran Corporation (NasdaqGS:CTRX) ** Healthcare Services Tony Perkins, VP, IR

United Therapeutics Corp. (NasdaqGS:UTHR) Biotechnology Andy Fisher, CSO

Spectrum Pharmaceuticals, Inc. (NasdaqGS:SPPI) Biotechnology Rajesh Shrotriya, Chairman, CEO & President

Epic Health Services, Inc. (Private) Healthcare Services John Garbarino, Chairman & CEO; Chris Roussos, President & COO;

3:00 PM Accuray Incorporated (NasdaqGS:ARAY) Medical Products & Devices Josh Levine, CEO

Vectura Group Plc (LSE:VEC) Pharmaceuticals Christopher Blackwell, Chief Executive

Humana Inc. (NYSE:HUM) Healthcare Services Steve McCulley, Chief Accounting Officer

Dr. Reddy's Laboratories Ltd. (BSE:500124) Pharmaceuticals Umang Vohra, EVP & Head North America Generics

INSYS Therapeutics, Inc. (NasdaqGM:INSY) Pharmaceuticals Michael Babich, President & CEO

Labcyte Inc. (Private) Life Sciences Mark Fischer-Colbrie, President & CEO

3:30 PM Sunesis Pharmaceuticals, Inc. (NasdaqCM:SNSS) Biotechnology Eric Bjerkholt, EVP, Corp Development & Finance, CFO

Aceto Corp. (NasdaqGS:ACET) Healthcare Services Salvatore Guccione, President & CEO

Patterson Companies, Inc. (NasdaqGS:PDCO) Healthcare Services Steve Armstrong, EVP & CFO; Ann Gugino, VP, Strategy & Planning

Cosmo Pharmaceuticals SpA (SWX:COPN) Biotechnology Alessandro Della Cha, CEO; Chris Tanner, CFO

AVANIR Pharmaceuticals (NasdaqGS:AVNR) Biotechnology Keith Katkin, CEO

HRA Pharma, SA (Private) Pharmaceuticals Erin Gainer, CEO

4:00 PM Merrimack Pharmaceuticals, Inc. (NasdaqGM:MACK) Biotechnology Robert Mulroy, President & CEO

Intercept Pharmaceuticals, Inc. (NasdaqGS:ICPT) Biotechnology Mark Pruzanski, CEO; Barbara Duncan, CFO

Chemed Corporation (NYSE:CHE) Healthcare Services Kevin McNamara, President & CEO

Oncolytics Biotech Inc (TSX:ONC) Biotechnology Brad Thompson, CEO

Vela Diagnostics Pte Ltd (Private) Life Sciences Michael Tillmann, President & CEO

4:30 PM Infinity Pharmaceuticals, Inc. (NasdaqGS:INFI) Biotechnology Julian Adams, President, R&D

Active Biotech AB (OM:ACTI) Biotechnology Tomas Leanderson, President & CEO

Novozymes A/S (CPSE:NZYM B) Biotechnology Rose Lance, Biopharma Business Development

DexCom, Inc. (NasdaqGS:DXCM) Medical Products & Devices Kevin Sayer, President & COO

Tonix Pharmaceuticals Holding Corp (NasdaqCM:TNXP) Biotechnology Seth Lederman, CEO

KaloBios Pharmaceuticals, Inc. (NasdaqGM:KBIO) Biotechnology David Pritchard, President & CEO

Page 6: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

AGENDA WEDNESDAY, JUNE 4, 2014 Jefferies 2014 Global Healthcare Conference

** Company not hosting a breakout session Presenting companies and speakers are subject to change.

BALLROOM I BREAKOUT ROOM: URIS

BALLROOM II BREAKOUT ROOM: JUILLIARD

BALLROOM III BREAKOUT ROOM: BROADWAY

BALLROOM IV BREAKOUT ROOM: CARNEGIE HALL

BALLROOM V BREAKOUT ROOM: ALVIN

MOROSCO, CONFERENCE LEVEL BREAKOUT ROOM: PLYMOUTH

7:30 AM Breakfast/Registration (Ballroom Level)

8:00 AM Repligen Corporation (NasdaqGS:RGEN) Life Sciences Walter Herlihy, Ph.D., President & CEO

Galapagos NV (ENXTBR:GLPG) Biotechnology Onno Van de Stolpe, CEO

Express Scripts, Inc. (NasdaqGS:ESRX) Healthcare Services Tim Wentworth, President; Cathy Smith, CFO

Mallinckrodt plc (NYSE:MNK) Pharmaceuticals Mark Trudeau, President & CEO; Matt Harbaugh, SVP & CFO

Ambu A/S (CPSE:AMBU B) Medical Products & Devices Lars Marcher, CEO

Sorrento Therapeutics, Inc. (OTCPK:SRNE) Biotechnology Henry Ji, President & CEO

8:30 AM Idera Pharmaceuticals, Inc. (NasdaqCM:IDRA) Biotechnology Sudhir Agrawal, CEO

Acceleron Pharma (NasdaqGM:XLRN) Biotechnology John Knopf, CEO & Founder

WellPoint, Inc. (NYSE:WLP) Healthcare Services Wayne DeVeydt, EVP & CFO

U.S. Physical Therapy, Inc. (NYSE:USPH) Healthcare Services Larry McAfee, EVP & CFO

Cytokinetics, Incorporated (NasdaqCM:CYTK) Biotechnology Robert Blum, President & CEO

Auspex Pharmaceuticals, Inc. (NasdaqGM:ASPX) Biotechnology Pratik Shah, CEO; John Schmid, CFO

9:00 AM Oncothyreon Inc. (NasdaqGS:ONTY) Biotechnology Robert Kirkman, MD, President & CEO

MorphoSys AG (XTRA:MOR) Biotechnology Jens Holstein, CFO

Salix Pharmaceuticals, Ltd. (NasdaqGS:SLXP)** Pharmaceuticals Carolyn Logan, President & CEO

Theravance Inc. (NasdaqGS:THRX) Biotechnology Rick E Winningham, Chairman & CEO

Veracyte, Inc. (NasdaqGM:VCYT) Life Sciences Bonnie Anderson, President & CEO; Shelly Guyer, CFO

Altegra Health, Inc. (Private)** Healthcare Services Kevin Barrett, CEO & President

9:30 AM CytRx Corporation (NasdaqCM:CYTR) Biotechnology Steven Kriegsman, President & CEO

Orion Corp. (HLSE:ORNBV) ** Pharmaceuticals Jari Karlson, CFO

AbbVie Inc. (NYSE:ABBV)** Pharmaceuticals Scott Brun, VP, Pharmaceutical Development

Alere Inc. (NYSE:ALR) Life Sciences Jon Russell, VP, Finance

Corium International, Inc. (NasdaqGM:COR)** Pharmaceuticals Peter Staple, President & CEO

bioTheranostics, Inc. (Private) Life Sciences Richard Ding, CEO

10:00 AM Orasure Technologies, Inc. (NasdaqGS:OSUR) Life Sciences Douglas Michels, President & CEO

ImmunoGen, Inc. (NasdaqGS:IMGN) Biotechnology Daniel Junius, President & CEO

Celgene Corporation (NasdaqGS:CELG)** Biotechnology Jacqualyn Fouse, EVP & CFO

BioScrip, Inc. (NasdaqGS:BIOS) Healthcare Services Rick Smith, CEO

Geron Corporation (NasdaqGS:GERN) Biotechnology John Scarlett, President & CEO

Catalyst Biosciences, Inc. (Private) Biotechnology Nassim Usman, CEO

10:30 AM Vanda Pharmaceuticals, Inc. (NasdaqGM:VNDA) Pharmaceuticals Mihael Polymeropoulos, MD, President & CEO

Celldex Therapeutics, Inc. (NasdaqGS:CLDX) Biotechnology Anthony Marucci, President & CEO

Becton, Dickinson and Company (NYSE:BDX) Medical Products & Devices Tom Polen, Worldwide Group President; Linda Tharby, Worldwide Group President

Transgene SA (ENXTPA:TNG)** Biotechnology Philippe Archinard, Chairman & CEO

CareCloud Corporation (Private) Healthcare Services Albert Santalo, Chairman & CEO

11:00 AM Endologix Inc (NasdaqGS:ELGX) Medical Products & Devices John McDermott, CEO

Mettler-Toledo International, Inc. (NYSE:MTD) Life Sciences Bill Donnelly, EVP

Actelion Ltd. (SWX:ATLN) Biotechnology Roland Haefeli, SVP, IR & Public Affairs

Gentiva Health Services Inc. (NasdaqGS:GTIV) Healthcare Services Eric Slusser, EVP & CFO

Supernus Pharmaceuticals, Inc. (NasdaqGM:SUPN)** Pharmaceuticals Jack Khattar, CEO; Greg Patrick, CFO

Kadmon Corporation (Private) Biotechnology Sam Waksal, Chairman & CEO

11:30 AM Fate Therapeutics, Inc. (NasdaqGM:FATE) Biotechnology Christian Weyer, President & CEO

Edwards Lifesciences Corp. (NYSE:EW) Medical Products & Devices Scott Ullem, CFO

Amgen Inc. (NasdaqGS:AMGN)** Biotechnology Arvind Sood, VP

Quality Systems, Inc. (NasdaqGS:QSII) Healthcare Services Steve Plochocki, President & CEO

Antares Pharma Inc. (NasdaqCM:ATRS) Pharmaceuticals Paul Wotton, CEO

Syndax Pharmaceuticals, Inc. (Private)** Pharmaceuticals Arlene Morris, CEO; John Pallies, CFO; Peter Ordentlich, CTO; Pamela Klein, CMO

Page 7: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

AGENDA WEDNESDAY, JUNE 4, 2014 Jefferies 2014 Global Healthcare Conference

** Company not hosting a breakout session Presenting companies and speakers are subject to change.

BALLROOM I

BREAKOUT ROOM: URIS BALLROOM II BREAKOUT ROOM: JUILLIARD

BALLROOM III BREAKOUT ROOM: BROADWAY

BALLROOM IV BREAKOUT ROOM: CARNEGIE HALL

BALLROOM V BREAKOUT ROOM: ALVIN

MOROSCO, CONFERENCE LEVEL BREAKOUT ROOM: PLYMOUTH

12:00 PM Break for Lunch (Ballroom Level)

12:15 PM PANEL: Key Takeaways from ASCO (Ballrooms 2-4)

Moderators: Jeffrey Holford, Senior Analyst, Pharmaceuticals; Thomas Wei, Senior Analyst, Biotechnology; Eun Yang, Senior Analyst, Biotechnology, Jefferies LLC

Panelists: Chandra Belani, Miriam Beckner Distinguished Professor of Medicine, Penn State College of Medicine & Deputy Director, Penn State Cancer Institute Joshua Brody, Director, Lymphoma Immunotherapy Program, Icahn School of Medicine at Mount Sinai Dawn Hershman, MD, Associate Professor of Medicin & Epidemiology, Columbia University Medical Center

1:30 PM GTx, Inc. (NasdaqGM:GTXI) Biotechnology Marc Hanover, President & COO

Epizyme, Inc. (EPZM) Biotechnology Jason Rhodes, President & CFO

ALK-Abello (CPSE:ALK B) Pharmaceuticals Jens Bager, President & CEO

Capital Senior Living Corp. (NYSE:CSU) Healthcare Services Lawrence Cohen, CEO; Carey Hendrickson, CFO

Five Prime Therapeutics, Inc. (NasdaqGS:FPRX) Biotechnology Lewis T. Williams, President & CEO; Julie Hambleton, CMO

Prosensa Holding N.V. (NasdaqGS:RNA) Biotechnology Hans Schikan, CEO

2:00 PM Verastem, Inc. (NasdaqGM:VSTM) Biotechnology Robert Forrester, President & CEO

Natus Medical Inc. (NasdaqGS:BABY)** Medical Products & Devices Jim Hawkins, CEO

Meridian Bioscience, Inc. (NasdaqGS:VIVO) Life Sciences Jack Kraeutler, CEO

Northwest Biotherapeutics, Inc. (NasdaqCM:NWBO)**

Biotechnology Linda Powers, CEO

PTC Therapeutics, Inc. (NasdaqGS:PTCT) Biotechnology Stuart Peltz, Ph.D., CEO; Shane Kovacs, CFO

2:30 PM Haemonetics Corp (NYSE:HAE) Medical Products & Devices Christopher Lindop, CFO & EVP, Business Development

OSI Systems, Inc. (NasdaqGS:OSIS)** Medical Products & Devices Alan Edrick, EVP & CFO

PAREXEL International Corporation (NasdaqGS:PRXL) Healthcare Services Josef von Rickenbach, Chairman & CEO; Ingo Bank, SVP & CFO

Ariad Pharmaceuticals Inc. (NasdaqGS:ARIA) Biotechnology Tim Clackson, President, R&D

Cell Therapeutics, Inc. (NasdaqCM:CTIC) Biotechnology James Bianco, CEO & President

Zogenix, Inc. (NasdaqGM:ZGNX) Pharmaceuticals Stephen Farr, President; Ann Rhoads, CFO

3:00 PM Array BioPharma, Inc. (NasdaqGM:ARRY) Biotechnology Ron Squarer, CEO

UDG Healthcare plc (LON:UDG) Healthcare Services Alan Ralph, CFO

Wright Medical Group, Inc. (NasdaqGS:WMGI) Medical Products & Devices Lance Berry, SVP & CFO

Healthcare Services Group Inc. (NasdaqGS:HCSG) Healthcare Services Daniel McCartney, CEO; Theodor Wahl, President & COO; Matthew McKee, Director of Marketing

NewLink Genetics Corporation (NasdaqGM:NLNK) Biotechnology Dr. Nicholas Vahanian, President & CMO

Vibra Healthcare LLC (Private) Healthcare Services Brad Hollinger, CEO

3:30 PM Pluristem Therapeutics, Inc. (NasdaqCM:PSTI) Biotechnology Karine Kleinhaus, Divisional VP, North America

Invacare Corp. (NYSE:IVC)** Medical Products & Devices Gerald Blouch, President & CEO

Recordati SpA (BIT:REC) Pharmaceuticals Fritz Squindo, CFO; Marianne Tatschke, Director of IR & Corporate Communication

Medical Facilities Corp. (TSX:DR) Healthcare Services Donald Schellpfeffer, CEO; Michael Salter, CFO

Mirati Therapeutics, Inc. (NasdaqCM:MRTX) Biotechnology Chuck Baum, President & CEO

Cytori Therapeutics (NasdaqGM:CYTX) Biotechnology Mark Saad, CFO

4:00 PM Nanostring Technologies, Inc. (NasdaqGM:NSTG) Life Sciences Brad Gray, President & CEO

OncoMed Pharmaceuticals, Inc. (NasdaqGS:OMED) Biotechnology Paul Hastings, Chairman & CEO

Stericycle, Inc. (NasdaqGS:SRCL) Healthcare Services Charlie Alutto, President & CEO

Sagent Pharmaceuticals (NasdaqGM:SGNT) Pharmaceuticals Jon Singer, CFO

Addus HomeCare Corporation (NasdaqGS:ADUS) Healthcare Services Mark Heaney, President & CEO; Dennis Meulemans, CFO

Zeltia SA (CATS:ZEL) Biotechnology José Luis Moreno, Capitals Markets & IR Director

4:30 PM Xenoport, Inc. (NasdaqGS:XNPT) Biotechnology Ronald W. Barrett, CEO

Argos Therapeutics, Inc. (NasdaqGM:ARGS) Biotechnology Jeff Abbey, President & CEO

BTG Plc (LSE:BTG) Biotechnology Louise Makin, CEO

MAXIMUS, Inc. (NYSE:MMS) Healthcare Services Bruce Caswell, President & GM Health Services; Lisa Miles, SVP, IR & Corporate Communication

Alphatec Holdings, Inc. (NasdaqGS:ATEC) Medical Products & Devices James Corbett, CEO

AltheaDx, Inc. (Private)** Life Sciences Greg Hamilton, CEO

Page 8: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

AGENDA THURSDAY, JUNE 5, 2014 Jefferies 2014 Global Healthcare Conference

** Company not hosting a breakout session Presenting companies and speakers are subject to change.

BALLROOM I BREAKOUT ROOM: URIS

BALLROOM II BREAKOUT ROOM: JUILLIARD

BALLROOM III BREAKOUT ROOM: BROADWAY

BALLROOM IV BREAKOUT ROOM: CARNEGIE HALL

BALLROOM V BREAKOUT ROOM: ALVIN

MOROSCO, CONFERENCE LEVEL BREAKOUT ROOM: PLYMOUTH

7:30 AM Breakfast/Registration

8:00 AM Amarin Corp Plc (NasdaqGM:AMRN) Biotechnology John Thero, President & CEO

Xencor, Inc. (NasdaqGM:XNCR) Biotechnology Bassil Dahiyat, President & CEO

Varian Medical Systems Inc. (NYSE:VAR)** Medical Products & Devices Spencer Sias, VP, IR

eHealth Inc (NasdaqGS:EHTH)

Healthcare Services Gary Lauer, CEO; Stuart Huizinga, CFO

Osiris Therapeutics, Inc. (NasdaqGM:OSIR) Biotechnology Lode Debrabandere, President & CEO

Cymabay Therapeutics, Inc. (OTCBB:CYMA) Pharmaceuticals Harold Van Wart, President & CEO; Sujal Shah, CFO

8:30 AM Eagle Pharmaceuticals Inc. (NasdaqGM:EGRX) Biotechnology Scott Tarriff, President & CEO

Orexo AB (OM:ORX) Pharmaceuticals Henrik Juuel, CFO

Regeneron Pharmaceuticals, Inc. (NasdaqGS:REGN)** Biotechnology Michael Aberman, VP, Strategy & IR

PDL BioPharma, Inc. (NasdaqGS:PDLI) Life Sciences John P. McLaughlin, President & CEO

AVEO Pharmaceuticals, Inc. (NasdaqGS:AVEO) Biotechnology Tuan Ha-Ngoc, President & CEO

9:00 AM Biotime Inc (AMEX:BTX) Biotechnology Michael West, CEO

Curis, Inc. (NasdaqGM:CRIS) Biotechnology Ali Fattaey, President & COO

Synageva BioPharma Corp (NasdaqGS:GEVA)** Biotechnology Sanj K. Patel, President & CEO

Bavarian Nordic A/S (CPSE:BAVA) Biotechnology Ole Larsen, CFO

diaDexus, Inc. (OTCPK:DDXS) Biotechnology Brian Ward, President & CEO

9:30 AM Arrowhead Research Corporation (NasdaqCM:ARWR) Biotechnology Christopher Anzalone, CEO; Bruce Given, COO

Stratec Biomedical AG (DB:SBS) Life Sciences Marcus Wolfinger, CEO

Arseus NV (ENXTBR:RCUS) Healthcare Services Ger Van Jeveren, CEO

Syneron Medical Ltd. (NasdaqGS:ELOS) Medical Products & Devices Shimon Eckhouse, Active Chairman; Hugo Goldman, CFO

Zealand Pharma A/S (CPSE:ZEAL) Biotechnology David Solomon, President & CEO

10:00 AM Ekso Bionics (OTCBB:EKSO) Medical Products & Devices Nathan Harding, CEO

Progenics Pharmaceuticals, Inc. (NasdaqGS:PGNX) Biotechnology Mark Baker, CEO

On Assignment Inc. (NYSE:ASGN) Healthcare Services Rand Blazer, President; Ted Hanson, CFO

Celladon Corporation (NasdaqGM:CLDN) Biotechnology Krisztina Zsebo, President & CEO

Regado Biosciences, Inc. (NasdaqCM:RGDO)** Biotechnology David Mazzo, CEO

Carbylan Therapeutics (Private) Medical Products & Devices David Renzi, President & CEO

10:30 AM Threshold Pharmaceuticals, Inc. (NasdaqCM:THLD) Biotechnology Harold E. Selick, Ph.D., CEO

Galena Biopharma, Inc. (NasdaqCM:GALE) Biotechnology Mark Ahn, President & CEO

Incyte Corporation (NasdaqGS:INCY)** Biotechnology Herve Hoppenot, President & CEO; Richard Levy, MD, EVP, Chief Drug Dev. & Medical Officer

Kamada Ltd. (TASE:KMDA) Biotechnology Gil Efron, CFO

ArQule Inc. (NasdaqGM:ARQL) Biotechnology Paolo Pucci, CEO; Brian Schwartz, CMO

Arno Therapeutics, Inc. (OTCPK:ARNI) Biotechnology Glenn Mattes, CEO; Alex Zukiwski, CMO

11:00 AM Synta Pharmaceuticals Corp. (NasdaqGM:SNTA) Biotechnology Vojo Vukovic, SVP & CMO

Affymetrix Inc. (NasdaqGS:AFFX) Life Sciences Gavin Wood, CFO

Puma Biotechnology, Inc. (NYSE:PBYI) Biotechnology Alan Auerbach, Chairman, CEO & President

Enzymotec, Ltd. (NasdaqGS:ENZY) Biotechnology Ariel Katz, President & CEO; Oren Bryan, CFO

Lumenis Ltd (NasdaqGS:LMNS) Medical Products & Devices Tzipi Ozer-Armon, CEO; Ophir Yakovian, CFO

Lombard Medical Technologies (NasdaqGM:EVAR) Medical Products & Devices Simon Hubbert, CEO

11:30 AM La Jolla Pharmaceutical Co. (NasdaqCM:LJPC) Biotechnology George Tidmarsh, President, CEO & Secretary

Neurocrine Biosciences, Inc. (NasdaqGS:NBIX)**

Biotechnology Kevin Gorman, President & CEO

Brookdale Senior Living Inc. (NYSE:BKD) Healthcare Services Andy Smith, CEO; Mark Ohlendorf, President & CFO

MediWound Ltd. (NasdaqGM:MDWD) Pharmaceuticals Gal Cohen, President & CEO; Sharon Malka, CFO

Skyepharma PLC (LSE:SKP) Pharmaceuticals Peter Grant, CEO

Helsinn Healthcare SA (Private) Pharmaceuticals William Mann, US CEO

Page 9: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

AGENDA THURSDAY, JUNE 5, 2014 Jefferies 2014 Global Healthcare Conference

** Company not hosting a breakout session Presenting companies and speakers are subject to change.

BALLROOM I BREAKOUT ROOM: URIS

BALLROOM II BREAKOUT ROOM: JUILLIARD

BALLROOM III BREAKOUT ROOM: BROADWAY

BALLROOM IV BREAKOUT ROOM: CARNEGIE HALL

BALLROOM V BREAKOUT ROOM: ALVIN

12:00 PM Break for Lunch (Ballroom Level)

12:30 PM Lion Biotechnologies, Inc. (OTCPK:LBIO) Biotechnology Manish Singh, CEO

Flamel Technologies SA (NasdaqGM:FLML) Pharmaceuticals Michael Anderson, CEO

Novo Nordisk A/S (CPSE:NOVO B) Pharmaceuticals Karsten Munk Knudsen, CVP of Finance & IT at NNI

Halozyme Therapeutics, Inc. (NasdaqGM:HALO) Biotechnology Helen Torley, President & CEO

Sucampo Pharmaceuticals, Inc. (NasdaqGM:SCMP) Pharmaceuticals Peter Greenleaf, CEO; Cary Claiborne, CFO; Silvia Taylor, SVP, IR & Corp Comm

1:00 PM Agenus Inc. (NasdaqCM:AGEN) Biotechnology Robert Stein, CSO

Sangamo Biosciences Inc. (NasdaqGS:SGMO) Biotechnology Edward Lanphier, President & CEO

Emergent BioSolutions Inc. (NYSE:EBS) Biotechnology Barry Labinger, President Biosciences Division

AngioDynamics Inc. (NasdaqGS:ANGO) Medical Products & Devices Mark Frost, CFO

Egalet Ltd. (NasdaqGM:EGLT) Pharmaceuticals Robert Radie, President & CEO

1:30 PM Ocera Therapeutics, Inc. (NasdaqGM:OCRX) Biotechnology Linda Grais, President & CEO

RedHill Biopharma Ltd. (TASE:RDHL) Pharmaceuticals Guy Goldberg, CBO

Biotest AG (DB:BIO3) Biotechnology Gregor Schulz, CEO

Alimera Sciences, Inc. (NasdaqGM:ALIM) Pharmaceuticals Dan Myers, President & CEO

Navidea Biopharmaceuticals, Inc (AMEX:NAVB) Life Sciences Thomas Tulip, President & CBO

2:00 PM Catalyst Pharmaceutical Partners Inc. (NasdaqCM:CPRX) Biotechnology Patrick McEnany, CEO; Steven Miller, CSO & COO

Orthofix International NV (NasdaqGS:OFIX) Medical Products & Devices Brad Mason, President & CEO; Mark Quick, IR

Carl Zeiss Meditec AG (XTRA:AFX) Medical Products & Devices Dr. Christian Müller, CFO

Mesoblast Limited (ASX:MSB) Biotechnology Silviu Itescu, CEO & MD

China Cord Blood Corporation (NYSE:CO)** Life Sciences Albert Chen, CFO; Kevin Zhang, VP, Corp Finance

2:30 PM Esperion Therapeutics, Inc. (NasdaqGM:ESPR) Biotechnology Timothy Mayleben, President & CEO

Spark Therapeutics, LLC (Private) ** Biotechnology Jeffrey Marrazzo, President & CEO

Innate Pharma S.A. (ENXTPA:IPH) Biotechnology Hervé Brailly, CEO

Dynavax Technologies Corporation (NasdaqCM:DVAX) Biotechnology Michael Ostrach, VP, CBO & Principal Financial Officer

Lipocine Inc. (NasdaqCM:LPCN) Pharmaceuticals Mahesh Patel, President & CEO

3:00 PM Symmetry Medical Inc. (NYSE:SMA) Medical Products & Devices Tom Sullivan, CEO

Fibrocell Science, Inc. (NYSE:FCSC) Biotechnology David Pernock, Chairman & CEO; Greg Weaver, SVP & CFO

MolMed S.p.A. (BIT:MLM) Biotechnology Claudio Bordignon, Chairman & CEO

Page 10: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

PARTICIPATING COMPANIES Jefferies 2014 Global Healthcare Conference PARTICIPATING COMPANIES AS OF 6/1

Participating companies are subject to change.

Biotechnology

• Ablynx NV (ENXTBR:ABLX)

• ACADIA Pharmaceuticals Inc. (NasdaqGM:ACAD)

• Acceleron Pharma (NasdaqGM:XLRN)

• AcelRx Pharmaceuticals, Inc. (NasdaqGM:ACRX)

• Acorda Therapeutics, Inc. (NasdaqGS:ACOR)

• Actelion Ltd. (SWX:ATLN)

• Active Biotech AB (OM:ACTI)

• Aegerion Pharmaceuticals, Inc. (NasdaqGS:AEGR)

• Aerie Pharmaceuticals, Inc. (NasdaqGM:AERI)

• Agenus Inc. (NasdaqCM:AGEN)

• Alcobra Ltd. (NasdaqCM:ADHD)

• Alkermes plc (NasdaqGS:ALKS)

• Amarin Corp Plc (NasdaqGM:AMRN)

• Ambit Biosciences Corporation (NasdaqGM:AMBI)

• Amgen Inc. (NasdaqGS:AMGN)

• Ampio Pharmaceuticals, Inc. (AMEX:AMPE)

• Aratana Therapeutics, Inc. (NasdaqGM:PETX)

• Arena Pharmaceuticals, Inc. (NasdaqGS:ARNA)

• Argos Therapeutics, Inc. (NasdaqGM:ARGS)

• Ariad Pharmaceuticals Inc. (NasdaqGS:ARIA)

• Arno Therapeutics, Inc. (OTCPK:ARNI)

• ArQule Inc. (NasdaqGM:ARQL)

• Array BioPharma, Inc. (NasdaqGM:ARRY)

• Arrowhead Research Corporation (NasdaqCM:ARWR)

• Aurinia Pharmaceuticals Inc. (TSXV:AUP)

• Auspex Pharmaceuticals, Inc. (NasdaqGM:ASPX)

• AVANIR Pharmaceuticals (NasdaqGS:AVNR)

• AVEO Pharmaceuticals, Inc. (NasdaqGS:AVEO)

• Basilea Pharmaceutica AG (SWX:BSLN) - 1x1s Only

• Bavarian Nordic A/S (CPSE:BAVA)

• Bellicum Pharmaceuticals, Inc. (Private)

• BIND Therapeutics, Inc. (NasdaqGS:BIND)

• BioSpecifics Technologies Corp. (NasdaqGM:BSTC)

• Biota Pharmaceuticals, Inc. (NasdaqGS:BOTA)

• Biotest AG (DB:BIO3)

• Biotime Inc (AMEX:BTX)

• BTG Plc (LSE:BTG)

• Catalyst Biosciences, Inc. (Private)

• Catalyst Pharmaceutical Partners Inc.

(NasdaqCM:CPRX)

• Celgene Corporation (NasdaqGS:CELG)

• Cell Therapeutics, Inc. (NasdaqCM:CTIC)

• Celladon Corporation (NasdaqGM:CLDN)

• Celldex Therapeutics, Inc. (NasdaqGS:CLDX)

• Cempra, Inc. (NasdaqGM:CEMP)

• Conatus Pharmaceuticals Inc. (NasdaqGM:CNAT)

• Concert Pharmaceuticals, Inc. (NasdaqGM:CNCE)

• Cosmo Pharmaceuticals SpA (SWX:COPN)

• Curis, Inc. (NasdaqGM:CRIS)

• Cytokinetics, Incorporated (NasdaqCM:CYTK)

• CytomX Therapeutics, Inc. (Private)

• Cytori Therapeutics (NasdaqGM:CYTX)

• CytRx Corporation (NasdaqCM:CYTR)

• diaDexus, Inc. (OTCPK:DDXS)

• Dicerna Pharmaceuticals, Inc. (NasdaqGS:DRNA)

• DYAX Corp (NasdaqGM:DYAX)

• Dynavax Technologies Corporation

(NasdaqCM:DVAX)

• Eagle Pharmaceuticals Inc. (NasdaqGM:EGRX)

• Emergent BioSolutions Inc. (NYSE:EBS)

• Enanta Pharmaceuticals, Inc. (NasdaqGS:ENTA)

• Enzymotec, Ltd. (NasdaqGS:ENZY)

• Epizyme, Inc. (EPZM)

• Esperion Therapeutics, Inc. (NasdaqGM:ESPR)

• Fate Therapeutics, Inc. (NasdaqGM:FATE)

• Fibrocell Science, Inc. (NYSE:FCSC)

• Five Prime Therapeutics, Inc. (NasdaqGS:FPRX)

• Flexion Therapeutics (NasdaqGM:FLXN)

• Galapagos NV (ENXTBR:GLPG)

• Galectin Therapeutics, Inc. (NasdaqCM:GALT)

• Galena Biopharma, Inc. (NasdaqCM:GALE)

• Genmab AS (CPSE:GEN)

• Geron Corporation (NasdaqGS:GERN)

• GlycoMimetics, Inc. (NasdaqGM:GLYC)

• GTx, Inc. (NasdaqGM:GTXI)

• Halozyme Therapeutics, Inc. (NasdaqGM:HALO)

• Heptares Therapeutics Ltd. (Private)

• Heron Therapeutics, Inc. (NasdaqCM:HRTX)

• Hyperion Therapeutics, Inc. (NasdaqGM:HPTX)

• Idera Pharmaceuticals, Inc. (NasdaqCM:IDRA)

• Immune Design Corp. (Private) - 1x1s Only

• ImmunoGen, Inc. (NasdaqGS:IMGN)

• Immunomedics, Inc. (NasdaqGM:IMMU)

• Incyte Corporation (NasdaqGS:INCY)

• Infinity Pharmaceuticals, Inc. (NasdaqGS:INFI)

• Innate Pharma S.A. (ENXTPA:IPH)

• Inovio Pharmaceuticals, Inc. (NYSE:INO)

• Intercept Pharmaceuticals, Inc. (NasdaqGS:ICPT)

• InterMune Inc. (NasdaqGS:ITMN) - 1x1s Only

• Juno Therapeutics Inc. (Private)

• Kadmon Corporation (Private)

• KaloBios Pharmaceuticals, Inc. (NasdaqGM:KBIO)

• Kamada Ltd. (TASE:KMDA)

• Kindred Biosciences, Inc. (NasdaqCM:KIN)

Page 11: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

PARTICIPATING COMPANIES Jefferies 2014 Global Healthcare Conference PARTICIPATING COMPANIES AS OF 6/1

Participating companies are subject to change.

• La Jolla Pharmaceutical Co. (NasdaqCM:LJPC)

• Lexicon Pharmaceuticals, Inc. (NasdaqGS:LXRX)

• Lion Biotechnologies, Inc. (OTCPK:LBIO)

• MannKind Corporation (NasdaqGM:MNKD)

• Medivation, Inc. (NasdaqGS:MDVN)

• Medivir AB (OM:MVIR B)

• Merrimack Pharmaceuticals, Inc. (NasdaqGM:MACK)

• Mesoblast Limited (ASX:MSB)

• Mirati Therapeutics, Inc. (NasdaqCM:MRTX)

• MolMed S.p.A. (BIT:MLM)

• MorphoSys AG (XTRA:MOR)

• Neostem, Inc. (NasdaqCM:NBS)

• NephroGenex, Inc. (NasdaqCM:NRX)

• Neurocrine Biosciences, Inc. (NasdaqGS:NBIX)

• NewLink Genetics Corporation (NasdaqGM:NLNK)

• Northwest Biotherapeutics, Inc. (NasdaqCM:NWBO)

• Novavax, Inc. (NasdaqGM:NVAX)

• Novozymes A/S (CPSE:NZYM B)

• NPS Pharmaceuticals Inc. (NasdaqGS:NPSP)

• Ocera Therapeutics, Inc. (NasdaqGM:OCRX)

• Oncolytics Biotech Inc (TSX:ONC)

• OncoMed Pharmaceuticals, Inc. (NasdaqGS:OMED)

• Oncothyreon Inc. (NasdaqGS:ONTY)

• Osiris Therapeutics, Inc. (NasdaqGM:OSIR)

• OvaScience, Inc. (NasdaqGM:OVAS)

• Pain Therapeutics, Inc. (NasdaqGS:PTIE)

• PaxVax, Inc. (Private)

• Pharming Group NV (ENXTAM:PHARM)

• Pluristem Therapeutics, Inc. (NasdaqCM:PSTI)

• Progenics Pharmaceuticals, Inc. (NasdaqGS:PGNX)

• Prosensa Holding N.V. (NasdaqGS:RNA)

• Protalix Biotherapeutics (AMEX:PLX)

• Prothena Corporation plc (NasdaqGM:PRTA)

• PTC Therapeutics, Inc. (NasdaqGS:PTCT)

• Puma Biotechnology, Inc. (NYSE:PBYI)

• Radius Health, Inc. (NasdaqGM:RDUS) - 1x1s Only

• Regado Biosciences, Inc. (NasdaqCM:RGDO)

• Regeneron Pharmaceuticals, Inc. (NasdaqGS:REGN)

• Rigel Pharmaceuticals, Inc. (NasdaqGS:RIGL)

• RXi Pharmaceuticals Corporation (NASDAQ: RXII)

• Sangamo Biosciences Inc. (NasdaqGS:SGMO)

• SciClone Pharmaceuticals, Inc. (NasdaqGS:SCLN)

• Seattle Genetics Inc. (NasdaqGS:SGEN)

• SIGA Technologies, Inc. (NasdaqGM:SIGA) - 1x1s Only

• Sophiris Bio, Inc. (TSX:SHS)

• Sorrento Therapeutics, Inc. (OTCPK:SRNE)

• Spark Therapeutics, LLC (Private)

• Spectrum Pharmaceuticals, Inc. (NasdaqGS:SPPI)

• Stemline Therapeutics, Inc. (NasdaqCM:STML)

• Sunesis Pharmaceuticals, Inc. (NasdaqCM:SNSS)

• Synageva BioPharma Corp (NasdaqGS:GEVA)

• Synta Pharmaceuticals Corp. (NasdaqGM:SNTA)

• Targacept, Inc. (NasdaqGS:TRGT)

• Theravance Inc. (NasdaqGS:THRX)

• Threshold Pharmaceuticals, Inc. (NasdaqCM:THLD)

• ThromboGenics NV (ENXTBR:THR) - 1x1s Only

• Tonix Pharmaceuticals Holding Corp

(NasdaqCM:TNXP)

• Transgene SA (ENXTPA:TNG)

• Transition Therapeutics Inc. (TSX:TTH)

• Trevena, Inc. (NasdaqGS:TRVN)

• TrovaGene, Inc. (NasdaqCM:TROV)

• Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE)

• uniQure N.V. (NasdaqGS:QURE)

• United Therapeutics Corp. (NasdaqGS:UTHR)

• Verastem, Inc. (NasdaqGM:VSTM)

• Xencor, Inc. (NasdaqGM:XNCR)

• Xenoport, Inc. (NasdaqGS:XNPT)

• XOMA Corporation (NasdaqGM:XOMA)

• Zealand Pharma A/S (CPSE:ZEAL)

• Zebra Biologics, Inc. (Private)

• Zeltia SA (CATS:ZEL)

• Zosano Pharma, Inc (Private) - 1x1s Only

Healthcare Services

• Acadia Healthcare Company (NasdaqGS:ACHC)

• Aceto Corp. (NasdaqGS:ACET)

• Addus HomeCare Corporation (NasdaqGS:ADUS)

• Aetna Inc. (NYSE:AET) - 1x1s Only

• Air Methods Corp. (NasdaqGS:AIRM) - 1x1s Only

• Albany Molecular Research, Inc. (NasdaqGS:AMRI)

• Almost Family, Inc. (NasdaqGS:AFAM)

• Altegra Health, Inc. (Private)

• Amedisys, Inc. (NasdaqGS:AMED)

• AMN Healthcare Services, Inc. (NYSE:AHS)

• Amplifon SpA (BIT:AMP) - 1x1s Only

• Arseus NV (ENXTBR:RCUS)

• BioScrip, Inc. (NasdaqGS:BIOS)

• Brookdale Senior Living Inc. (NYSE:BKD)

• Capital Senior Living Corp. (NYSE:CSU)

• CareCloud Corporation (Private)

• Catamaran Corporation (NasdaqGS:CTRX)

• Cerner Corporation (NasdaqGS:CERN)

• Charles River Laboratories International, Inc.

(NYSE:CRL)

• Chemed Corporation (NYSE:CHE)

Page 12: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

PARTICIPATING COMPANIES Jefferies 2014 Global Healthcare Conference PARTICIPATING COMPANIES AS OF 6/1

Participating companies are subject to change.

• Cigna Corporation (NYSE:CI) - 1x1s Only

• Community Health Systems, Inc. (NYSE:CYH)

• Cross Country Healthcare, Inc. (NasdaqGS:CCRN)

• eHealth Inc (NasdaqGS:EHTH)

• Elements Behavioral Health, Inc. (Private)

• Ensign Group (NasdaqGS:ENSG) - 1x1s Only

• Epic Health Services, Inc. (Private)

• Express Scripts, Inc. (NasdaqGS:ESRX)

• Gentiva Health Services Inc. (NasdaqGS:GTIV)

• Hanger, Inc. (NYSE:HGR)

• Health Insurance Innovations, Inc. (NasdaqGM:HIIQ)

• Healthcare Services Group Inc. (NasdaqGS:HCSG)

• Henry Schein, Inc. (NasdaqGS:HSIC)

• HMS Holdings Corp (NasdaqGS:HMSY) - 1x1s Only

• Humana Inc. (NYSE:HUM)

• ICON plc (NasdaqGS:ICLR)

• IPC The Hospitalist Company, Inc. (NasdaqGS:IPCM)

• Kindred Healthcare Inc. (NYSE:KND)

• Magellan Health Services, Inc. (NasdaqGS:MGLN)

• MAXIMUS, Inc. (NYSE:MMS)

• Medical Facilities Corp. (TSX:DR)

• MEDNAX, Inc. (NYSE:MD)

• Merge Healthcare Inc. (NasdaqGS:MRGE)

• MHM Services, Inc. (Private)

• MWI Veterinary Supply (NasdaqGS:MWIV)

• NMC Health Plc (LSE:NMC) - 1x1s Only

• On Assignment Inc. (NYSE:ASGN)

• Owens & Minor Inc. (NYSE:OMI) - 1x1s Only

• PAREXEL International Corporation (NasdaqGS:PRXL)

• Patterson Companies, Inc. (NasdaqGS:PDCO)

• Quality Systems, Inc. (NasdaqGS:QSII)

• RadNet, Inc. (NasdaqGM:RDNT)

• Stericycle, Inc. (NasdaqGS:SRCL)

• U.S. Physical Therapy, Inc. (NYSE:USPH)

• UDG Healthcare plc (LON:UDG)

• VCA Antech Inc. (NasdaqGS:WOOF)

• Vibra Healthcare LLC (Private)

• WellPoint, Inc. (NYSE:WLP)

• WuXi PharmaTech (Cayman) Inc. (NYSE:WX)

Life Sciences

• Abaxis Inc (NasdaqGS:ABAX)

• Affymetrix Inc. (NasdaqGS:AFFX)

• Agilent Technologies Inc. (NYSE:A)

• Alere Inc. (NYSE:ALR)

• AltheaDx, Inc. (Private)

• BioClinica, Inc. (Private)

• Bio-Rad Laboratories, Inc. (NYSE:BIO)

• bioTheranostics, Inc. (Private)

• Bruker Corporation (NasdaqGS:BRKR)

• Cambrex Corp (NYSE:CBM)

• Cellular Dynamics International, Inc.

(NasdaqGM:ICEL)

• Cepheid (NasdaqGS:CPHD)

• China Cord Blood Corporation (NYSE:CO)

• ChromaDex Corporation (OTCPK:CDXC)

• Covance Inc. (NYSE:CVD)

• Enzo Biochem, Inc. (NYSE:ENZ)

• Evotec AG (XTRA:EVT)

• EXACT Sciences Corp (NasdaqCM:EXAS)

• Genomic Health (NasdaqGS:GHDX)

• Labcyte Inc. (Private)

• Lantheus Medical Imaging, Inc. (Private) - 1x1s Only

• Meridian Bioscience, Inc. (NasdaqGS:VIVO)

• Mettler-Toledo International, Inc. (NYSE:MTD)

• Nanosphere, Inc. (NasdaqGM:NSPH)

• Nanostring Technologies, Inc. (NasdaqGM:NSTG)

• Navidea Biopharmaceuticals, Inc (AMEX:NAVB)

• Orasure Technologies, Inc. (NasdaqGS:OSUR)

• Organovo Holdings, Inc. (NYSEMKT:ONVO)

• PDL BioPharma, Inc. (NasdaqGS:PDLI)

• Quintiles Transnational Holdings Inc. (NYSE:Q)

• Repligen Corporation (NasdaqGS:RGEN)

• Sequenom Inc. (NasdaqGS:SQNM)

• Sigma-Aldrich Corporation (NasdaqGS:SIAL)

• Stratec Biomedical AG (DB:SBS)

• Vela Diagnostics Pte Ltd (Private)

• Veracyte, Inc. (NasdaqGM:VCYT)

Medical Products & Devices

• Abiomed Inc (NasdaqGS:ABMD)

• Accuray Incorporated (NasdaqGS:ARAY)

• Align Technology Inc. (NasdaqGS:ALGN)

• Alphatec Holdings, Inc. (NasdaqGS:ATEC)

• Ambu A/S (CPSE:AMBU B)

• AngioDynamics Inc. (NasdaqGS:ANGO)

• Becton, Dickinson and Company (NYSE:BDX)

• Cantel Medical Corp (NYSE:CMN)

• Carbylan Therapeutics (Private)

• Carl Zeiss Meditec AG (XTRA:AFX)

• DENTSPLY International Inc. (NasdaqGS:XRAY)

• DexCom, Inc. (NasdaqGS:DXCM)

• Direct Flow Medical, Inc. (Private)

• Edwards Lifesciences Corp. (NYSE:EW)

• Ekso Bionics (OTCBB:EKSO)

• Endologix Inc (NasdaqGS:ELGX)

Page 13: JUNE 2-5, 2014 -  · PDF fileplace June 2-5 at the Grand Hyatt in New York City. ... Corcept Therapeutics Incorporated (NasdaqCM:CORT) Pharmaceuticals Charlie Robb, CFO

PARTICIPATING COMPANIES Jefferies 2014 Global Healthcare Conference PARTICIPATING COMPANIES AS OF 6/1

Participating companies are subject to change.

• Globus Medical, Inc. (NYSE:GMED)

• Haemonetics Corp (NYSE:HAE)

• Insulet Corporation (NasdaqGS:PODD)

• Integra LifeSciences Holdings Corporation

(NasdaqGS:IART)

• Intuity Medical, Inc. (Private)

• Invacare Corp. (NYSE:IVC)

• Lombard Medical Technologies (NasdaqGM:EVAR)

• Lumenis Ltd (NasdaqGS:LMNS)

• MiMedx Group, Inc. (NasdaqCM:MDXG)

• Natus Medical Inc. (NasdaqGS:BABY)

• Orthofix International NV (NasdaqGS:OFIX)

• OSI Systems, Inc. (NasdaqGS:OSIS)

• Oxford Immunotec Global PLC (NasdaqGM:OXFD)

• Royal Philips (ENXTAM:PHIA)

• Sirona Dental Systems, Inc. (NasdaqGS:SIRO) - 1x1s

Only

• STAAR Surgical Co. (NasdaqGM:STAA)

• Stryker Corp. (NYSE:SYK)

• Symmetry Medical Inc. (NYSE:SMA)

• Syneron Medical Ltd. (NasdaqGS:ELOS)

• Unilife Corporation (NasdaqGM:UNIS)

• Varian Medical Systems Inc. (NYSE:VAR)

• West Pharmaceutical Services, Inc. (NYSE:WST)

• Wright Medical Group, Inc. (NasdaqGS:WMGI)

• ZELTIQ Aesthetics, Inc. (NasdaqGS:ZLTQ) – 1x1s Only

Pharmaceuticals

• AbbVie Inc. (NYSE:ABBV)

• Akorn, Inc. (NasdaqGS:AKRX)

• Alimera Sciences, Inc. (NasdaqGM:ALIM)

• ALK-Abello (CPSE:ALK B)

• Almirall, S.A. (CATS:ALM) - 1x1s Only

• Anacor Pharmaceuticals, Inc. (NasdaqGM:ANAC)

• Antares Pharma Inc. (NasdaqCM:ATRS)

• Aquinox Pharmaceuticals Inc. (NasdaqGM:AQXP)

• Astellas Pharma Inc. (TSE:4503) - 1x1s Only

• AstraZeneca PLC (LSE:AZN)

• Auxilium Pharmaceuticals, Inc. (NasdaqGS:AUXL)

• Avion Pharmaceuticals, LLC (Private)

• Collegium Pharmaceutical, Inc. (Private)

• Corcept Therapeutics Incorporated

(NasdaqCM:CORT)

• Corium International, Inc. (NasdaqGM:COR)

• Cymabay Therapeutics, Inc. (OTCBB:CYMA)

• DepoMed Inc. (NasdaqGS:DEPO)

• Dr. Reddy's Laboratories Ltd. (BSE:500124)

• Edison Pharmaceuticals, Inc. (Private)

• Egalet Ltd. (NasdaqGM:EGLT)

• Flamel Technologies SA (NasdaqGM:FLML)

• GlaxoSmithKline plc (LSE:GSK) - 1x1s Only

• H. Lundbeck A/S (CPSE:LUN)

• Helsinn Healthcare SA (Private)

• Hikma Pharmaceuticals plc (LSE:HIK) – 1x1s Only

• Horizon Pharma, Inc. (NasdaqGS:HZNP)

• HRA Pharma, SA (Private)

• INSYS Therapeutics, Inc. (NasdaqGM:INSY)

• Lipocine Inc. (NasdaqCM:LPCN)

• Mallinckrodt plc (NYSE:MNK)

• MediWound Ltd. (NasdaqGM:MDWD)

• NeuroDerm, Ltd. (Private) - 1x1s Only

• Nora Therapeutics, Inc. (Private)

• Novo Nordisk A/S (CPSE:NOVO B)

• OpKo Health, Inc (NYSE:OPK)

• Oramed Pharmaceuticals Inc. (NasdaqCM:ORMP)

• Orexo AB (OM:ORX)

• Orion Corp. (HLSE:ORNBV)

• Pacira Pharmaceuticals Inc. (NasdaqGS:PCRX)

• Perrigo Co. (NYSE:PRGO)

• Pharmascience Inc. (Private)

• Recordati SpA (BIT:REC)

• RedHill Biopharma Ltd. (TASE:RDHL)

• Revance Therapeutics, Inc. (NasdaqGM:RVNC)

• Roche Holding Ltd (SWX:ROG)

• Sagent Pharmaceuticals (NasdaqGM:SGNT)

• Salix Pharmaceuticals, Ltd. (NasdaqGS:SLXP)

• Shire plc (LSE:SHP)

• Skyepharma PLC (LSE:SKP)

• Sucampo Pharmaceuticals, Inc. (NasdaqGM:SCMP)

• Supernus Pharmaceuticals, Inc. (NasdaqGM:SUPN)

• Swedish Orphan Biovitrum AB (OM:SOBI)

• Syndax Pharmaceuticals, Inc. (Private)

• Teva Pharmaceutical Industries Limited (NasdaqGS:TEVA)

• The Medicines Company (NasdaqGS:MDCO)

• TherapeuticsMD, Inc. (AMEX:TXMD)

• Vanda Pharmaceuticals, Inc. (NasdaqGM:VNDA)

• Vectura Group Plc (LSE:VEC)

• Zogenix, Inc. (NasdaqGM:ZGNX)

REITs

• Medical Properties Trust (NYSE:MPW)

• Physicians Realty Trust (NYSE:DOC)

• Senior Housing Properties Trust (NYSE:SNH)